Discriminative stimulus properties of nicotine at low doses: The effects of caffeine preload

Behavioural Pharmacology

Volumn 9, Issue 3, 1998, Pages 219-229

  Duka, T ^a   Tasker, R ^a   Russell, K ^a   Stephens, D N ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Caffeine; Drug discrimination; Humans; Nicotine; Vigilance

Indexed keywords

CAFFEINE; NICOTINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COFFEE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DISCRIMINATION; FEMALE; HUMAN; LEARNING; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SELF CONCEPT; SMOKING;

ADULT; AROUSAL; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; GENERALIZATION, STIMULUS; HUMANS; MALE; NICOTINE; NICOTINIC AGONISTS;

EID: 0031776952     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Baettig JJ (1985). The physiological effects of coffee consumption. In Clifford MN, Wilson KC (editors). Coffee: botany, biochemistry and production of beans and beverages. Westport, CT: AVI. pp. 394-439.
2. Benowitz NL, Rorchet H, Jacob P (1990). Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. In Wonnacott S, Russell MAH, Stolerman IP editors. Nicotine psychopharmacology: molecular, cellular, and behavioural aspects. New York: Oxford University Press. pp. 112-157.
3. Blanchard J, Sawers SJA (1983). Comparative pharmacokinetics of caffeine in young and elderly men. J Pharmacokinet Biopharm 11:109-126. In Goodman Gilman A, Rall TW, Nies AS, Taylor P, editors. (1990) Goodman and Gilman's The pharmacological basis of therapeutics, 8th edn. New York: Pergamon Press. pp. 1650-1735.
4. Blanchard J, Sawers SJA (1983). Comparative pharmacokinetics of caffeine in young and elderly men. J Pharmacokinet Biopharm 11:109-126. In Goodman Gilman A, Rall TW, Nies AS, Taylor P, editors. (1990) Goodman and Gilman's The pharmacological basis of therapeutics, 8th edn. New York: Pergamon Press. pp. 1650-1735.
5. Duka T, Attfield S (1996). Discriminative stimulus and vigilance effects of nicotine in humans. Behav Phamacol 7 (Suppl 1):32.
6. Duka T, Redemann B, Voet B (1995). Scopolamine and lorazepam exert different patterns of effects in a test battery assessing stages of information processing. Psychopharmacology 119:315-324.
7. Duka T, Stephens DN, Russell C, Tasker R (1998). Discriminative stimulus properties of low doses of ethanol in humans. Psychopharmacology 136:379-389.
8. Evans SM, Griffiths RR (1991). Dose-related caffeine discrimination in normal volunteers: individual differences in subjective effects and self-reported cues. Behav Phamacol 2:345-356.
9. File SE, Bond AJ, Lister RG (1982). Interaction between effects of caffeine and lorazepam in performance tests and self ratings. J Clin Psychopharmacol 2:102-106.
10. Gilbert RM (1976). Caffeine as a drug of abuse. In Gibbins RJ, Israel Y, Kalant H, Popham RE, Schmidt W, Smart RG, editors. Research advances in alcohol and drug problems, vol. 3. New York: John Wiley. pp. 49-176.
11. Goldberg SR, Henningfield JE (1988). Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of i.v. drug injection. Pharmacol, Biochem Behav 30:227-234.
12. Goldstein A, Kaizer S, Warren R (1965). Psychotrophic effects of caffeine in man. II. Alertness, psychomotor coordination and mood. J Phamacol Exp Ther 150:146-151.
13. Griffiths RR, Mumford GK (1995). Caffeine - a drug of abuse? In Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press.
14. Griffiths RR, Woodson PP (1988). Reinforcing effects of caffeine in humans. J Pharmacol Exp Ther 246:21-29.
15. Griffiths RR, Evans SM, Heishman SJ, Preston KL, Sannerud CA, Wolf B, Woodson PP (1990). Low-dose caffeine physical dependence in humans. J Pharmacol Exp Ther 255:1123-1132.
16. Henningfield JE, Goldberg SR (1988). Pharmacologic determinants of tobacco self-administration by humans. Pharmacol, Biochem Behav 30:221-226.
17. Henningfield JE, Miyasato K, Jasinki DR (1985). Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 234:1-12.
18. Hindmarch I, Kerr JS, Sherwood N (1990). Effects of nicotine gum on psychomotor performance in smokers and nonsmokers. Psychopharmacology 100:535-541.
19. Istvan J, Matarazzo JD (1984). Tobacco, alcohol and caffeine use: a review of their interrelationships. Psychol Bull 95:301-326.
20. Kamien JB, Bickel WK, Hughes JR, Higgins ST, Smith BJ (1993). Drug discrimination in humans compared to nonhumans: current status and future directions. Psychopharmacology 111:259-270.
21. Kallman WM, Kallman MJ, Harry GJ, Woodson PP, Rosencrans JA (1982). Nicotine as a discriminative stimulus in human subjects. In Colpaert FC, Slangen JL, editors. Drug discrimination: applications in CNS pharmacology. New York: Elsevier. pp. 211-218.
22. Kuznicki JT, Turner LS (1986). The effects of caffeine on caffeine users and non-users. Physiol Behav 37:397-408.
23. Lamb RJ, Preston KL, Schindler CW, Meisch RA, Davis F, Katz JL, et al. (1991). The reinforcing and subjective effects of morphine in post addicts: a dose response study. J Pharmacol Exp Ther 259:1165-1173.
24. Lieberman HR, Wurtman RJ, Emde GG, Coviella ILG (1987a). The effects of caffeine and aspirin on mood and performance. J Clin Psychopharmacol 7:315-320.
25. Lieberman HR, Wurtman RJ, Emde GG, Roberts C, Coviella ILG (1987b). The effects of low dose caffeine on human performance and mood. Psychopharmacology (Berlin) 92:308-312.
26. Loke WH, Meliska CJ (1984). Effects of caffeine use and ingestion on a protracted visual vigilance task. Psychopharmacology (Berlin) 84:54-57.
27. Mumford GK, Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K, Griffiths RR (1994). Discriminative stimulus and subjective effects of theobromine and caffeine in humans. Psychopharmacology 115:1-8.
28. Nemeth-Coslett R, Benowitz NL, Robinson N, Henningfield EJ (1988). Nicotine gum: chew rate, subjective effects and plasma nicotine. Pharmacol, Biochem Behav 29:747-751.
29. Perkins KA, Grobe JE, Epstein LH, Caggiula A, Stiller RL, Jacob RG (1993). Chronic and acute tolerance to subjective effects of nicotine. Pharmacol, Biochem Behav 45:375-381.
30. Perkins KA, Sexton JE, Stiller RL, Fonte C, DiMarco A, Goettler J, et al. (1994a). Subjective and cardiovascular responses to nicotine combined with caffeine during rest and casual activity. Psychopharmacology 113: 438-444.
31. Perkins KA, DiMarco A, Grobe JE, Scierka A, Stiller, RL (1994b). Nicotine discrimination in male and female smokers. Psychopharmacology 116:407-413.
32. Ray RL, Nellis MJ, Brady JV, Foltin RW (1986). Nicotine and caffeine effects on the task-elicited blood pressure response. Addict Behav 11:31-36.
33. Rose JE (1986). Cigarete smoking blocks caffeine-induced arousal. Alcohol Drug Res 7:49-55.
34. Rose JE, Behm FM (1991). Psychophysiological interactions between caffeine and nicotine. Pharmacol, Biochem Behav 38:333-337.
35. Rose JE, Zinser MC, Tashkin DP, Newcombe R, Ertle A (1984). Subjective response to cigarette smoking following airway anesthetised. Addict Behav 9:211-215.
36. Schielke B, Duka T, Mager T (1993). Sakkaden als pharmakodynamische Methode. In Lange L, Jaeger H, Seifert W, Klingmann I, editors. Konzepte in der Humanpharmakologie. Pharmakologische Modelle für die Arzneimittelentwicklung. Berlin: Springer. pp. 301-312.
37. Silverman K, Griffiths RR (1992). Low-dose caffeine discrimination and self-reported mood effects in normal volunteers. J Exp Anal Behav 57:91-107.
38. Stolerman IP (1991). Measures of stimulus generalisation in drug discrimination experiments. Behav Pharmacol 2:265-282.
39. Strivastava ED, Russell MAH, Feyerabend C, Masterson JG, Rhodes J (1991). Sensitivity and tolerance to nicotine in smokers and nonsmokers. Psychopharmacology 105:63-68.
40. Swift CG Tiplady B (1988). The effects of age on the response to caffeine. Psychopharmacology 94:29-31.
41. US Department of Health and Human Services (USDHHS) (1988). The health consequences of smoking: nicotine addiction. Washington, DC: US Government Printing Office.
42. Wesnes K, Warburton DM (1983). Effects of smoking on rapid visual information processing performance. Neuropsychobiology 9:223-229.
43. Zagona SV, Zurcher LA (1965). An analysis of some psychosocial variables associated with smoking behaviour in a college sample. Psycholog Rep 17:967-978.